Search
Abcellera Biologics Inc
ABCLAdd to Watchlist
11.880USD
+0.750+6.74%
Close 11-06 16:00（ET）
3.85BMarket Cap
LossP/E TTM
After-hours 19:49 (ET)11.900USD-0.015-0.13%
After-hours 19:49 (ET)Today
+6.74%
5 Days
-3.18%
1 Month
-7.40%
6 Months
+146.47%
Year to Date
+247.37%
1 Year
+203.84%
Key Figures
11.560Open
11.950High
464.01KVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
0.14%Turnover Ratio
11.130Prev. Close
10.760Low
5.45MTurnover
LossP/E Static
4.30P/B
0.00%Div Yield TTM
-10.86%ROA
15.01552wk High
61.53Volume Ratio
-162.86MNet Profit
323.91MShares
-0.4793EPS TTM
1.12Beta
-14.68%ROE
2.74552wk Low
10.69%Amplitude
100.00%Gross Margin
3.85BMarket Cap
20.28Reward/Risk
5.46%Risk Rate
More news coming soon, stay tuned...
Abcellera Biologics Inc's Score
0.05vs previous score
Forecast8.00
Financial Health6.82
Technical4.51
Valuation Dimensions9.17
Institutional Confidence3.00
Risk Assessment3.57
Media Coverage
Coverage Level
Very Low
Very High
Neutral
Analyst Rating
Abcellera Biologics Inc Technical Analysis
Technical Indicators
Sell
Summary
Neutral
Moving Average
Neutral
Financial Indicators
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
Earnings
Next reporting date
2026-11-09
Reporting Period
2026Q2
Earnings / Forecast
-0.18/-0.14
Revenue / Forecast
4.05M/7.78M
Abcellera Biologics Inc Profile
SectorBiotechnology & Medical Research
Ticker SymbolABCL
Number of employees596
CountryCanada
Ownership
| Shareholders | Proportion |
|---|---|
| Thermopylae Holdings Ltd | 18.38% |
| Baker Bros. Advisors LP | 9.01% |
| Capital World Investors | 4.38% |
| Two Sigma Investments, LP | 3.52% |
| Shareholder Types | Proportion |
|---|---|
| Corporation | 18.39% |
| Hedge Fund | 15.77% |
| Investment Advisor | 11.92% |
| Research Firm | 4.81% |
Related Instruments
-0.79%
+1.43%
+1.07%
-0.14%
+0.38%
-0.22%
+0.03%
-0.41%
+0.02%
-0.20%
+0.85%
-1.57%
-1.04%
+0.28%
+5.27%
-0.16%
+0.16%
-0.80%
+1.46%
+3.63%Popular Instruments
51290.600
-208.500 (-0.41%)
26964.500
+329.300 (+1.24%)
7380.000
+23.100 (+0.31%)
12797.000
-1.000 (-0.01%)
58142.000
+876.000 (+1.53%)
6140.600
-37.200 (-0.60%)
89.857
-0.176 (-0.20%)
342.370
-1.800 (-0.52%)
186.640
+5.040 (+2.78%)
4065.670
-33.020 (-0.81%)
FAQs
What is the current price of Abcellera Biologics Inc (ABCL)?
The current price of Abcellera Biologics Inc (ABCL) is 11.88.
What is the symbol of Abcellera Biologics Inc?
The ticker symbol of Abcellera Biologics Inc is ABCL.
What is the 52-week high of Abcellera Biologics Inc?
The 52-week high of Abcellera Biologics Inc is 15.02.
What is the 52-week low of Abcellera Biologics Inc?
The 52-week low of Abcellera Biologics Inc is 2.75.
What is the market capitalization of Abcellera Biologics Inc?
The market capitalization of Abcellera Biologics Inc is 3.85B.
Is Abcellera Biologics Inc (ABCL) currently rated as Buy, Hold, or Sell?
According to analysts, Abcellera Biologics Inc (ABCL) has an overall rating of Buy, with a price target of 16.80.
What is the Earnings Per Share (EPS TTM) of Abcellera Biologics Inc (ABCL)?
The Earnings Per Share (EPS TTM) of Abcellera Biologics Inc (ABCL) is -0.48.